Solution 'desperately required' for 'serious problem' with medtech standards in EU
This article was originally published in Clinica
The European Commission's approach towards adopting international medical device standards has been too strict over the past few years and is causing a "serious problem" for the medtech sector, according to an independent report carried out on behalf of the commission. There are concerns that if the situation does not improve, harmonized European standards (hEN) may ultimately no longer be the preferred route for companies to show compliance with the essential requirements of the EU medical device directives.
You may also be interested in...
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.
EU drug industry federation, EFPIA, is concerned that an increase in protectionist trade measures by some countries could result in tit-for-tat policies that could hamper the global response to contain COVID-19.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-nine guidance documents have been posted on the tracker since its last update.